Tianjin Pharmaceutical Da Ren Tang Group’s Parent Lifts Stake to 43.09%

SGX Filings

Aug 04

Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced that JinYao Global Pte. Ltd., a wholly owned unit of Tianjin Pharmaceutical Holdings Co., completed its six-month share-buy programme on Aug, 3 2026.

Between Feb, 4 2026 and the end of the plan, JinYao Global bought 724,200 S-shares on the Singapore Exchange for a total of about 2.8 million Singapore dollars, or an average of roughly USD 2.89 per share.

Following the purchases, the parent company’s stake in Tianjin Pharmaceutical Da Ren Tang Group rose to 43.09% from 42.997%, with its S-share holding increasing to 5.989 million shares from 5.265 million.

The company said the transactions complied with all relevant regulations, stayed within the announced spending cap and will not reduce the public float or alter the firm’s control structure.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/news/1110996532"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1110996532\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1110996532?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-04 18:12","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1110996532","market":"sg","top_or_hot":-1,"title":"Tianjin Pharmaceutical Da Ren Tang Group’s Parent Lifts Stake to 43.09%","media":"SGX Filings","content":"<p>Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced that JinYao Global Pte. Ltd., a wholly owned unit of Tianjin Pharmaceutical Holdings Co., completed its six-month share-buy programme on Aug, 3 2026.</p>\n<p>Between Feb, 4 2026 and the end of the plan, JinYao Global bought 724,200 S-shares on the Singapore Exchange for a total of about 2.8 million Singapore dollars, or an average of roughly USD 2.89 per share.</p>\n<p>Following the purchases, the parent company’s stake in Tianjin Pharmaceutical Da Ren Tang Group rose to 43.09% from 42.997%, with its S-share holding increasing to 5.989 million shares from 5.265 million.</p>\n<p>The company said the transactions complied with all relevant regulations, stayed within the announced spending cap and will not reduce the public float or alter the firm’s control structure.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Tianjin Pharmaceutical Da Ren Tang Group’s Parent Lifts Stake to 43.09%</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTianjin Pharmaceutical Da Ren Tang Group’s Parent Lifts Stake to 43.09%\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1083912268\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">SGX Filings </p>\n<p class=\"h-time\">2026-08-04 18:12</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced that JinYao Global Pte. Ltd., a wholly owned unit of Tianjin Pharmaceutical Holdings Co., completed its six-month share-buy programme on Aug, 3 2026.</p>\n<p>Between Feb, 4 2026 and the end of the plan, JinYao Global bought 724,200 S-shares on the Singapore Exchange for a total of about 2.8 million Singapore dollars, or an average of roughly USD 2.89 per share.</p>\n<p>Following the purchases, the parent company’s stake in Tianjin Pharmaceutical Da Ren Tang Group rose to 43.09% from 42.997%, with its S-share holding increasing to 5.989 million shares from 5.265 million.</p>\n<p>The company said the transactions complied with all relevant regulations, stayed within the announced spending cap and will not reduce the public float or alter the firm’s control structure.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"T14.SI","symbol_name":"达仁堂","start_time":0,"source_url":"","article_id":"1110996532","we_media_id":"1083912268","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1110996532","pubTimestamp":1785838337,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"SGX Filings","introduction":"Fastest News on SGX Filings ","home_visible":1,"id":"1083912268","head_image":"https://community-static.tradeup.com/news/57d1beae95c40ebe9f2698a436562e39"},"summary":"Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced that JinYao Global Pte. Ltd., a wholly owned unit of Tianjin Pharmaceutical Holdings Co., completed its six-month share-buy...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"T14.SI":"达仁堂"},"translate_title":"天津医药大仁堂集团母公司增持股份至43.09%","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"T14.SI":1},"content_text":"Tianjin Pharmaceutical Da Ren Tang Group Corporation Limited announced that JinYao Global Pte. Ltd., a wholly owned unit of Tianjin Pharmaceutical Holdings Co., completed its six-month share-buy programme on Aug, 3 2026.\nBetween Feb, 4 2026 and the end of the plan, JinYao Global bought 724,200 S-shares on the Singapore Exchange for a total of about 2.8 million Singapore dollars, or an average of roughly USD 2.89 per share.\nFollowing the purchases, the parent company’s stake in Tianjin Pharmaceutical Da Ren Tang Group rose to 43.09% from 42.997%, with its S-share holding increasing to 5.989 million shares from 5.265 million.\nThe company said the transactions complied with all relevant regulations, stayed within the announced spending cap and will not reduce the public float or alter the firm’s control structure.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}